[PRECISION MEDICINE WITH MOLECULAR TARGETED DRUGS IN RHEUMATOID ARTHRITIS]

Arerugi. 2020;69(2):110-118. doi: 10.15036/arerugi.69.110.

[Article in Japanese]

Author

Ryosuke Hanaoka¹

Affiliation

¹ Department of Rheumatology, Kamitsuga General Hospital.

PMID: 32188822
DOI: 10.15036/arerugi.69.110

No abstract available

Keywords: anti-cyclic citrullinated peptide antibody; biomarker; omics; precision medicine; shared epitope.

MeSH terms

Arthritis, Rheumatoid / therapy*
Humans
Molecular Targeted Therapy*
Precision Medicine*